Effects of Recombinant Human Soluble Thrombomodulin (rhs-TM) on Clot-induced Coagulation in Human Plasma
- 1 January 1998
- journal article
- letter
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 80 (12) , 925-929
- https://doi.org/10.1055/s-0037-1615390
Abstract
Recent studies have suggested that clot-bound thrombin plays an important role in thrombus growth. In this study, we examined the effects of recombinant human soluble thrombomodulin (rhsTM) on clot-induced coagulation. rhsTM enhanced the activation of protein C by clots, and attenuated clot-induced thrombin generation and fibrinopep-tide A (FPA) production in a dose-dependent manner. The inhibitory effect of rhsTM was abolished by anti-protein C antibody. The inhibitory effect of rhsTM on clot-induced thrombin generation continued for over 60 min after the addition of the clot, while an active site-directed thrombin inhibitor, argatroban, produced a more transient inhibition. rhsTM also inhibited the regrowth of the clot in 125I-fibrinogen-supplemented plasma. We also examined the effect of rhsTM by thromboelastography; rhsTM reduced the growth of the clot but had little effect on the time to begin clotting, while heparin and Fragmin (low molecular weight heparin) had effects opposite to those of rhsTM. These findings suggest that rhs-TM attenuates the growth of the clot by activating protein C and inhibiting further thrombin generation in the clot.Keywords
This publication has 10 references indexed in Scilit:
- In Vitro Anticoagulant Properties of a Minimum Functional Fragment of Human Thrombomodulin and In Vivo Demonstration of its Benefit as an Anticoagulant in Extracorporeal Circulation Using a Monkey ModelThrombosis and Haemostasis, 1998
- Review : Abnormalities in the protein C anticoagulant pathway detected by a novel assay using human thrombomodulinLupus, 1997
- The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis)Blood Coagulation & Fibrinolysis, 1997
- The Shape of Thrombomodulin and Interactions with Thrombin as Determined by Electron MicroscopyJournal of Biological Chemistry, 1996
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- Comparison of the Anticoagulant Activities of Thrombin Inhibitors as Assessed by Thromboelastographic AnalysisSeminars in Thrombosis and Hemostasis, 1995
- Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor‐induced disseminated intravascular coagulation in ratsAmerican Journal of Hematology, 1994
- Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in ratsThrombosis Research, 1993
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.Proceedings of the National Academy of Sciences, 1989